An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients-Reference-Cited by-同舟云学术

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

Published:2016-02-18 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Reijm Esther A.,Sieuwerts Anieta M.,Smid Marcel,Vries Joan Bolt-de,Mostert Bianca,Onstenk Wendy,Peeters Dieter,Dirix Luc Y.,Seynaeve Caroline M.,Jager Agnes,de Jongh Felix E.,Hamberg Paul,van Galen Anne,Kraan Jaco,Jansen Maurice P. H. M.,Gratama Jan W.,Foekens John A.,Martens John W. M.,Berns Els M. J. J.,Sleijfer Stefan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2155-y

Reference51 articles.

1. Thompson AM, Jordan LB, Quinlan P, Anderson E, Skene A, Dewar JA, et al. Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS). Breast Cancer Res. 2010;12(6):R92.

2. Gong Y, Han EY, Guo M, Pusztai L, Sneige N. Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy. Cancer. 2011;117(4):705–13.

3. Amir E, Miller N, Geddie W, Freedman O, Kassam F, Simmons C, et al. Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer. J Clin Oncol. 2012;30(6):587–92.

4. Pancholi S, Lykkesfeldt AE, Hilmi C, Banerjee S, Leary A, Drury S, et al. ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2. Endocr Relat Cancer. 2008;15(4):985–1002.

5. Miller TW, Balko JM, Arteaga CL. Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer. J Clin Oncol. 2011;29(33):4452–61.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial;Breast Cancer Research and Treatment;2024-01-31

2. The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management;Cancers;2023-11-17

3. CTCs in Early Breast Cancer;Circulating Tumor Cells;2023

4. Circulating Tumor Cells in Breast Cancer;Interdisciplinary Cancer Research;2023

5. Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes;Cancers;2022-11-18